How can technology be used in clinical trials to align with scientific advancements?

Boost your GCP E6 (R3) exam readiness. Improve your understanding with engaging, insightful questions. Test yourself with hints and detailed explanations. Prepare effectively!

Multiple Choice

How can technology be used in clinical trials to align with scientific advancements?

Explanation:
Using technology in clinical trials to align with scientific advancements means making the trial conduct responsive to who participants are and to the specific design goals of the study. Modern tools enable this by supporting flexible, data-driven approaches rather than rigid, one-size-fits-all methods. For example, wearable devices and electronic health records can capture relevant endpoints in real time, while adaptive or decentralized designs can adjust procedures based on interim findings and participant needs. This improves data quality, safety monitoring, and efficiency, and keeps the trial in step with evolving science and regulatory expectations. Choosing to stick with traditional designs ignores participant diversity and new methodological options. Merely collecting more data without adjusting the trial design can overwhelm teams and still miss meaningful insights. Replacing informed consent with a digital banner would fail to protect participant rights and violate ethical and regulatory standards.

Using technology in clinical trials to align with scientific advancements means making the trial conduct responsive to who participants are and to the specific design goals of the study. Modern tools enable this by supporting flexible, data-driven approaches rather than rigid, one-size-fits-all methods. For example, wearable devices and electronic health records can capture relevant endpoints in real time, while adaptive or decentralized designs can adjust procedures based on interim findings and participant needs. This improves data quality, safety monitoring, and efficiency, and keeps the trial in step with evolving science and regulatory expectations.

Choosing to stick with traditional designs ignores participant diversity and new methodological options. Merely collecting more data without adjusting the trial design can overwhelm teams and still miss meaningful insights. Replacing informed consent with a digital banner would fail to protect participant rights and violate ethical and regulatory standards.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy